Precipio Inc

PRPO

Company Profile

  • Business description

    Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

  • Contact

    4 Science Park
    3rd Floor
    New HavenCT06511
    USA

    T: +1 203 787-7888

    E: [email protected]

    https://www.precipiodx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    71

Stocks News & Analysis

stocks

This Cheap ASX REIT may be overlooked

Takeover strengthens portfolio outlook for ASX REIT.
stocks

Do AI labs like Anthropic and OpenAI have economic moats?

Leading AI labs are building economic moats to stave off commodification threats.
stocks

12 picks for an income portfolio - Q3 2026 update

Passive income growth continues to be strong but two picks are facing challenges.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,937.0059.300.67%
CAC 407,832.8829.550.38%
DAX 4025,277.68190.410.76%
Dow JONES (US)51,896.13241.180.47%
FTSE 10010,656.28104.230.99%
HKSE24,271.2059.850.25%
NASDAQ27,306.9959.18-0.22%
Nikkei 22569,030.9211.19-0.02%
NZX 50 Index13,827.6278.270.57%
S&P 5007,815.223.680.05%
S&P/ASX 2008,783.2066.600.76%
SSE Composite Index3,797.2416.55-0.43%

Market Movers